153 related articles for article (PubMed ID: 36346944)
1. Identification of PHB2 as a Potential Biomarker of Luminal A Breast Cancer Cells Using a Cell-Specific Aptamer.
Liu M; Wang Z; Li S; Deng Y; He N
ACS Appl Mater Interfaces; 2022 Nov; 14(46):51593-51601. PubMed ID: 36346944
[TBL] [Abstract][Full Text] [Related]
2. Precise discrimination of Luminal A breast cancer subtype using an aptamer in vitro and in vivo.
Liu M; Zhang B; Li Z; Wang Z; Li S; Liu H; Deng Y; He N
Nanoscale; 2020 Oct; 12(38):19689-19701. PubMed ID: 32966497
[TBL] [Abstract][Full Text] [Related]
3. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
4. Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells.
Liu M; Yang T; Chen Z; Wang Z; He N
Biomater Sci; 2018 Nov; 6(12):3152-3159. PubMed ID: 30349922
[TBL] [Abstract][Full Text] [Related]
5. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
6. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
Zhang WY; Chen HL; Chen QC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
[TBL] [Abstract][Full Text] [Related]
7. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.
Speransky S; Serafini P; Caroli J; Bicciato S; Lippman ME; Bishopric NH
Breast Cancer Res Treat; 2019 Jul; 176(2):271-289. PubMed ID: 31006104
[TBL] [Abstract][Full Text] [Related]
8. A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells.
Cong Y; Zhang SY; Li HM; Zhong JJ; Zhao W; Tang YJ
Int J Biol Macromol; 2023 Dec; 252():126450. PubMed ID: 37634779
[TBL] [Abstract][Full Text] [Related]
9. Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy.
Qiao Y; Shi Y; Ji M; Wang Z; Bai X; Zhang K; Yin K; Zhang Y; Chen X; Zhang Y; Lu J; Zhao J; Liu K; Yuan B
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129002. PubMed ID: 38176501
[TBL] [Abstract][Full Text] [Related]
10. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Sett A; Borthakur BB; Bora U
Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
[TBL] [Abstract][Full Text] [Related]
11. Aptamer selection and applications for breast cancer diagnostics and therapy.
Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
[TBL] [Abstract][Full Text] [Related]
12. Identification of the target protein of the metastatic colorectal cancer-specific aptamer W3 as a biomarker by aptamer-based target cells sorting and functional characterization.
Li W; Wu CC; Wang S; Zhou L; Qiao L; Ba W; Liu F; Zhan L; Chen H; Yu JS; Fang J
Biosens Bioelectron; 2022 Oct; 213():114451. PubMed ID: 35700603
[TBL] [Abstract][Full Text] [Related]
13. Selection of aptamers against triple negative breast cancer cells using high throughput sequencing.
Ferreira D; Barbosa J; Sousa DA; Silva C; Melo LDR; Avci-Adali M; Wendel HP; Rodrigues LR
Sci Rep; 2021 Apr; 11(1):8614. PubMed ID: 33883615
[TBL] [Abstract][Full Text] [Related]
14. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX.
Dastjerdi K; Tabar GH; Dehghani H; Haghparast A
Biotechnol Appl Biochem; 2011; 58(4):226-30. PubMed ID: 21838796
[TBL] [Abstract][Full Text] [Related]
15. Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation.
Song Z; Mao J; Barrero RA; Wang P; Zhang F; Wang T
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261145
[TBL] [Abstract][Full Text] [Related]
16. Cancer protein biomarker discovery based on nucleic acid aptamers.
Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
[TBL] [Abstract][Full Text] [Related]
17. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
18. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
Liu Z; Duan JH; Song YM; Ma J; Wang FD; Lu X; Yang XD
J Transl Med; 2012 Jul; 10():148. PubMed ID: 22817844
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2.
Wu J; Wang C; Li X; Song Y; Wang W; Li C; Hu J; Zhu Z; Li J; Zhang W; Lu Z; Yang CJ
PLoS One; 2012; 7(9):e46393. PubMed ID: 23029506
[TBL] [Abstract][Full Text] [Related]
20. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]